Literature DB >> 17724574

[Methylphenidate in adults with attention-deficit/hyperactivity disorder].

M Kösters, S Weinmann, T Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17724574     DOI： 10.1007/s00115-007-2331-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  12 in total

Review 1.  [ADHD in adulthood--guidelines based on expert consensus with DGPPN support].

Authors:  D Ebert; J Krause; C Roth-Sackenheim
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

2.  A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theresa Harpold; Stephanie Dunkel; Meghan Dougherty; Megan Aleardi; Thomas Spencer
Journal:  Biol Psychiatry       Date:  2005-12-20       Impact factor: 13.382

3.  A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

Authors:  Pieter J Carpentier; Cor A J de Jong; Boukje A G Dijkstra; Cor A G Verbrugge; Paul F M Krabbe
Journal:  Addiction       Date:  2005-12       Impact factor: 6.526

4.  Educational and occupational outcome of hyperactive boys grown up.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M E Hynes
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-09       Impact factor: 8.829

5.  Attention deficit disorders in adults.

Authors:  C T Gualtieri; M G Ondrusek; C Finley
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

6.  Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

Authors:  S Kuperman; P J Perry; G R Gaffney; B C Lund; K A Bever-Stille; S Arndt; T L Holman; D J Moser; J S Paulsen
Journal:  Ann Clin Psychiatry       Date:  2001-09       Impact factor: 1.567

7.  A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.

Authors:  Thomas Spencer; Joseph Biederman; Timothy Wilens; Robert Doyle; Craig Surman; Jefferson Prince; Eric Mick; Megan Aleardi; Kathleen Herzig; Stephen Faraone
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

8.  Young adult outcome of hyperactive children: adaptive functioning in major life activities.

Authors:  Russell A Barkley; Mariellen Fischer; Lori Smallish; Kenneth Fletcher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-02       Impact factor: 8.829

9.  Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Authors:  Frances R Levin; Suzette M Evans; Daniel J Brooks; Aparna S Kalbag; Fatima Garawi; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2005-08-15       Impact factor: 4.492

10.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.